Treatment Overview
Vitreoretinal Surgery for Advanced Age-related Macular Degeneration (AMD) in Korea is a microsurgical intervention aimed at managing severe complications of AMD, such as submacular hemorrhage, vitreous hemorrhage, macular scarring, and retinal detachment. This surgery is indicated when conservative treatments like anti-VEGF injections or laser therapy are insufficient to preserve vision.
Korea is internationally recognized for advanced vitreoretinal surgery programs that integrate:
- Microincision vitrectomy surgery (25G/27G) for minimal trauma and faster recovery
- Submacular hemorrhage displacement or removal using specialized instruments
- Intraoperative OCT-guided surgery for precise visualization of the macula
- Adjunctive use of tissue plasminogen activator (tPA) for subretinal clot dissolution
- Combined procedures with cataract surgery if necessary
- AI-assisted surgical planning and retinal mapping
This program aims to restore retinal structure, clear hemorrhage, and stabilize vision in patients with advanced AMD.
Purpose & Benefits
Purpose
- Remove or displace submacular hemorrhage caused by neovascular AMD
- Clear vitreous hemorrhage interfering with vision
- Manage macular scarring or epiretinal membranes
- Prevent progression to irreversible central vision loss
- Restore retinal anatomy and function
- Complement adjunctive therapies such as anti-VEGF injections
Benefits
- Minimally invasive microsurgical approach with high precision
- Real-time intraoperative OCT ensures accurate membrane or hemorrhage removal
- Rapid postoperative recovery compared to traditional surgery
- Can be combined with cataract surgery to improve visual outcomes
- Reduces risk of permanent central vision loss in advanced AMD
- Personalized surgical planning using AI-assisted imaging
Ideal Candidates
- Patients with advanced neovascular AMD with submacular hemorrhage
- Individuals with vitreous hemorrhage secondary to AMD
- Patients with macular scarring or epiretinal membrane formation
- High-risk AMD patients not responding adequately to anti-VEGF therapy
- Individuals requiring combined vitreoretinal and cataract procedures
Possible Risks & Complications
While vitreoretinal surgery is generally safe, potential risks include:
Common/Moderate Risks
- Mild postoperative inflammation or discomfort
- Temporary blurred vision
- Minor retinal edema or hemorrhage
Rare/Serious Risks
- Retinal tear or detachment
- Endophthalmitis (intraocular infection)
- Persistent macular edema
- Recurrence of submacular hemorrhage
- Severe vision loss in rare cases
Korean specialists minimize risks through:
- Microincision 25G/27G vitrectomy for minimal trauma
- Intraoperative OCT-guided visualization
- Careful membrane and clot removal using advanced microsurgical instruments
- Postoperative OCT and fundus monitoring for early detection of complications
Related Diagnostic & Treatment Techniques
- Pars Plana Vitrectomy (PPV) – Core surgical technique for hemorrhage and membrane removal
- Submacular Hemorrhage Surgery – Displacement or aspiration of subretinal clots
- Epiretinal Membrane / ILM Peeling – Prevents traction and recurrence
- Intraoperative OCT Guidance – Ensures precise surgical manipulation
- Adjunctive Anti-VEGF Therapy – Stabilizes neovascularization
- Cataract Surgery Combination – Enhances visual outcomes when lens opacity exists
Treatment Process in Korea
Step 1 – Preoperative Assessment
- Comprehensive eye examination including visual acuity, OCT, and fundus imaging
- Assessment of hemorrhage, membrane, or scarring location
- Preoperative planning for microincision vitrectomy and adjunctive procedures
Step 2 – Surgical Planning
- Decide microincision gauge (25G/27G)
- Determine need for submacular hemorrhage removal or displacement
- Plan ILM/ERM peeling if necessary
- Assess need for combined cataract surgery
Step 3 – Vitreoretinal Surgery
- Local or general anesthesia
- Microincision vitrectomy to remove vitreous traction and hemorrhage
- Submacular hemorrhage managed with tPA-assisted displacement or aspiration
- Epiretinal or internal limiting membrane peeling as indicated
- Retinal tamponade (gas or silicone oil) if required
Step 4 – Postoperative Evaluation
- OCT imaging to confirm retinal reattachment and hemorrhage resolution
- Visual acuity assessment and intraocular pressure monitoring
- Anti-inflammatory eye drops prescribed
Step 5 – Follow-Up & Maintenance
- Regular OCT and fundus examinations
- Additional interventions only if complications or recurrence occur
Duration: 90–240 minutes depending on complexity
Setting: Advanced vitreoretinal surgery center or hospital
Recovery & After-Care
After-Care Guidelines
- Avoid heavy lifting, bending, or eye rubbing for several weeks
- Use prescribed anti-inflammatory drops
- Monitor for flashes, floaters, or sudden vision changes
- Attend all scheduled postoperative visits
Recovery Timeline
- Immediate: Mild blurred vision and eye discomfort
- 1–2 Weeks: Inflammation subsides, initial visual improvement
- 1–3 Months: OCT confirms restored macular contour and retinal stability
- Long-Term: Periodic monitoring ensures no recurrence or further macular complications
Results & Longevity
Expected Results
- Clearance or displacement of submacular hemorrhage
- Improved retinal anatomy and visual stabilization
- Reduced risk of permanent central vision loss
- Ability to continue adjunctive anti-VEGF therapy if needed
Longevity
- Permanent improvement at treated sites with appropriate follow-up
- Lifelong OCT and fundus monitoring recommended
- Combined surgical and medical management enhances long-term outcomes
Why Korea Is a Top Destination
- Highly experienced vitreoretinal surgeons specialized in advanced AMD
- Microincision 25G/27G vitrectomy for minimal trauma and faster recovery
- Intraoperative OCT guidance for precision surgery
- AI-assisted surgical planning and preoperative mapping
- Access to combined procedures (cataract + vitrectomy + submacular hemorrhage management)
- High success rates and low complication rates in advanced AMD surgery
Unique Korean Innovations
- Intraoperative OCT-assisted submacular hemorrhage and membrane surgery
- AI-assisted preoperative macular mapping
- Microincision 27G vitrectomy for minimal trauma
- Combination surgery protocols (vitrectomy + cataract + anti-VEGF)
- Longitudinal imaging dashboards for serial postoperative evaluation
Cost Range (Indicative Estimate)
| Package | Price (KRW) | Approx. USD | Inclusions |
|---|---|---|---|
| Standard Vitreoretinal AMD Surgery | ₩4,500,000 – ₩7,500,000 | ~$3,500 – $5,800 | 25G/27G vitrectomy + ERM/ILM peeling + OCT follow-up |
| Surgery + Submacular Hemorrhage Management | ₩6,000,000 – ₩9,500,000 | ~$4,600 – $7,300 | tPA-assisted hemorrhage displacement + vitrectomy + OCT monitoring |
| Surgery + Cataract Combination | ₩7,500,000 – ₩12,000,000 | ~$5,800 – $9,200 | Combined vitrectomy + cataract extraction + anti-VEGF therapy + follow-up |
Popular Clinics in Korea
- B&VIIT Eye Center (Seoul)
- Dream Eye Center (Seoul)
- BGN Eye Clinic (Seoul & Busan)
- Kim’s Eye Hospital (Seoul)
- Seoul National University Hospital Retina Center
- NUNE Eye Hospital (Daegu)
- Glory Seoul Eye Clinic
- Gangnam Severance Hospital Ophthalmology
